Vaxxinity Inc.

0.00
-0.05 (-100.00%)
At close: Mar 04, 2025, 9:30 AM
0.10
49600.00%
Pre-market: Jun 20, 2024, 09:30 AM EDT

Vaxxinity Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a 66K 557K n/a
Cost of Revenue 2.23M 1.68M 1.94M 52K 107K
Gross Profit -2.23M -1.68M -1.87M 505K -107K
Operating Income -58.28M -75.98M -125.08M -32.28M -13.66M
Interest Income 2.09M 1.26M 9K 1K 435K
Pretax Income -56.93K -75.22M -137.18M -39.96M -14.16M
Net Income -56.93K -75.21M -138.01M -35.38M -14.22M
Selling & General & Admin 22.39M 28.35M 51.83M 12.22M 3M
Research & Development 33.66M 47.63M 71.38M 20.57M 10.66M
Other Expenses n/a n/a -8.37M -5.76M -27K
Operating Expenses 56.05M 75.98M 123.2M 32.79M 13.66M
Interest Expense 696K 514K 840K 1.18M 435K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 58.28M 75.98M 125.14M 32.84M 13.66M
Income Tax -56.93K -12K 840K -4.58M 56K
Shares Outstanding (Basic) 126.51K 125.94M 125.39M 125.45M 125.45M
Shares Outstanding (Diluted) 126.51K 125.94M 125.39M 125.45M 125.45M
EPS (Basic) -0.45 -0.6 -1.1 -0.28 -0.11
EPS (Diluted) -0.45 -0.6 -1.1 -0.28 -0.11
EBITDA -56.05K -74.3M -135.23M -31.57M -13.58M
Depreciation & Amortization 2.23K 1.68M 1.1M 717K 107K